We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (383)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
758 result(s) found, displaying 251 to 275
-
Scheduling decisions (final)Notification of amendments to the Poisons Standard in relation to Delegate-only final decisions and New Chemical Entities (NCEs), April 2022
-
Meeting statementsTherapeutic Goods Advertising Consultative Committee, 21 March 2022 communique
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 31, 8 February 2022
-
Corporate reportsTGA's Half-yearly Performance Snapshot Report for July - December 2021 is now available.
-
Corporate reportsTGA publishes a Half-Yearly Performance Report (The Snapshot). The Snapshot provides statistical information on our performance highlights for the July to December period
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 30, 14 January 2022
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 29, 7 January 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 April 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 April 2022
-
Corporate reportsPrescription opioid tracking research
-
TGA laboratory testing reportsTest results of compliance testing against TGO110 of available and imported nicotine vaping products are now published on the TGA website.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement, Meeting 65, 10 February 2022
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement, Meeting 64, 9 December 2021
-
Corporate reportsMedicines Safety Update - Information for health professionals
-
Scheduling decisions (final)Public notice - Delegate-only decisions to amend the Poisons Standard and New Chemical Entities (NCEs)
-
Scheduling decisions (final)Final decision on proposed amendment to the Poisons Standard relating to sodium nitrite (Joint ACMS-ACCS #28, June 2021)
-
Meeting statementsAdvisory Committee on Vaccines, meeting 28, 22 December 2021
-
Meeting statementsAdvisory Committee on Medicines, meeting statement now available
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 27, 1 December 2021
-
TGA laboratory testing reportsIn consultation with the TGA, Edgewell has taken a precautionary approach and commenced a recall of all batches of these three products from the Australian market.
-
Corporate reportsThe 2020-21 TGA Regulator Performance Framework Self-assessment (KPI) Report has now been published
-
-
Meeting statementsA meeting of the TGACC was held 6 December 2021. The Communique has now been published.
-
Scheduling decisions (final)Final decisions on proposed amendments to the Poisons Standard.